This upcoming January 20, 2021, MaRS and Merck Canada are launching the Lung Cancer Innovation Challenge. The competition asks Ontario-based innovators to identify, implement and scale solutions that can enhance a lung cancer patient’s journey by seeking to reduce the length of time between diagnosis and treatment for lung cancer patients, and enable improved treatment outcomes. Finalists will receive up to $100,000 for their submission with the potential for additional funding to scale their solution across Ontario. The challenge’s virtual launch features a panel discussion on the barriers and opportunities associated with the diagnosis and treatment of lung cancer. Panelists representing a diverse range of perspectives across the healthcare system — including patients, healthcare providers and other innovators — will share their experiences, and speak to the additional challenges posed by the COVID-19 pandemic.